Clinical trials: Adjuvant Chemotherapy for SBA
Small Bowel Adenocarcinoma, Adjuvant Chemotherapy for SBA
Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma
The utility of adjuvant chemotherapy in the management of Small Bowel Adenocarcinoma (SBA) remains unproven and awaits the results of a large, global, prospective, phase III, randomised, controlled trial.
- Trial name
- BALLAD (NCT02502370)
- Testing
- observation alone, LV5FU2, FOLFOX
- Where
- France
- Volunteers
- 100 people
- Sponsor
- Centre Hospitalier Universitaire Dijon